Single-Agent Doxorubicin Adjuvant Chemotherapy for Resectable Grade 2/3 Soft Tissue Sarcomas: A Retrospective Study.
Background: Soft tissue sarcomas (STS) are rare but aggressive tumors. Although surgery and radiotherapy are standard treatments for localized STS, the role of adjuvant chemotherapy, particularly doxorubicin, in high-grade STS is debated. Methods: This retrospective study evaluated the effectiveness...
| Publicado en: | Oncology (08909091) Vol. 40; no. 2; pp. 106 - 115 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | pictorial research tables/charts Journal Article |
| Publicado: |
MJH Life Sciences
Mar2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |